Table 3 Diagnostic values of the screening tools* for development of disabilities, mortality and hospital admission
| Â | Sensitivity (95% C.I.) | Specificity (95% C.I.) | Positive predicted value (95% C.I.) | Negative predicted value (95% C.I.) | Area under the Curve (95% C.I.) |
|---|---|---|---|---|---|
Development of Disabilities (n = 426) | |||||
GFI | 71 (62-79) | 63 (57-68) | 38 (31-45) | 87 (81-90) | 67 (61-73) |
TFI | 62 (52-71) | 71 (65-76) | 40 (33-49) | 85 (80-89) | 66 (60-72) |
SPQ | 83 (74-89) | 48 (42-54) | 34 (29-41) | 89 (83-93) | 65 (60-71) |
Mortality (n = 532) | |||||
GFI | 73 (44-91) | 54 (50-58) | 4 (2-8) | 98 (96-99) | 64 (50-77) |
TFI | 67 (39-87) | 61 (56-65) | 5 (2-8) | 98 (96-99) | 64 (50-78) |
SPQ | 71 (42-90) | 41 (37-46) | 3 (1-6) | 98 (94-98) | 56 (42-71) |
Hospital admission (n = 430) | |||||
GFI | 52 (40-64) | 55 (50-60) | 20 (15-26) | 84 (79-89) | 54 (46-61) |
TFI | 53 (41-64) | 65 (60-70) | 24 (18-32) | 87 (82-90) | 60 (52-67) |
SPQ | 76 (65-85) | 44 (39-49) | 22 (17-28) | 90 (84,94) | 60 (53-67) |